Which topical nonsteroidal anti-inflammatory drug (NSAID) is recommended for hand osteoarthritis pain?

Topical Diclofenac 1% Gel for Hand Pain

For hand osteoarthritis pain, use topical diclofenac sodium 1% gel as your first-line pharmacological treatment. This is the most strongly recommended topical NSAID based on current international guidelines and clinical evidence 1.

Why Topical Diclofenac Specifically

Topical diclofenac 1% gel is the only topical NSAID with:

• Strong guideline support from both ACR/Arthritis Foundation (2019) and EULAR (2018) specifically for hand OA 2, 1
• Direct evidence in hand OA showing small but meaningful improvements in pain and function after 8 weeks compared to placebo 1
• FDA approval for hand osteoarthritis treatment 3

The EULAR guidelines explicitly state that topical NSAIDs are preferred over systemic treatments due to their favorable safety profile, with topical NSAIDs being the "first-line pharmacological treatment of choice" 1.

Clinical Application

Dosing and administration:

• Apply 2 grams of diclofenac sodium 1% gel to each affected hand, four times daily
• Maximum daily dose: 32 grams total across all affected joints
• Rub gently into the skin over the affected joints

When to use it:

• Best for patients with a limited number of affected hand joints
• Particularly appropriate for elderly patients or those with cardiovascular, gastrointestinal, or renal comorbidities where oral NSAIDs pose higher risks 1, 4
• Consider oral NSAIDs only when a large number of joints are affected, making topical application impractical 1

Safety Profile

The safety advantage is substantial:

• Similar efficacy to oral NSAIDs but with far less systemic exposure 3, 5
• Pooled safety data shows similar low rates of adverse effects in high-risk patients (age ≥65, hypertension, diabetes, cardiovascular disease) compared to low-risk patients 1
• Main side effects are local application site reactions; serious systemic events (GI bleeding, cardiovascular events) are rare 5, 6

Important Caveats

Limitations to acknowledge:

• Evidence shows only small improvements in pain and function—set realistic expectations with patients 1
• Long-term efficacy data beyond 8-12 weeks are limited 1
• Recent meta-analysis suggests approximately 70% of the treatment effect may be attributable to contextual (placebo) effects rather than specific drug action 7
• Most effective for inflammatory nociceptive pain phenotypes; patients with predominantly nociplastic or neuropathic-like pain may not respond well 8

Alternative Topical Options

If diclofenac is unavailable or not tolerated:

• Topical capsaicin is an option but has frequent local burning/stinging sensations that limit tolerability 1
• Other topical NSAIDs lack specific evidence in hand OA
• Topical heat application is reasonable as self-management but has weak evidence 1

When Topical Treatment Isn't Enough

If topical diclofenac provides insufficient relief after 2-4 weeks:

1. Consider oral NSAIDs (lowest effective dose, limited duration, assess GI/CV/renal risk) 1
2. Intra-articular corticosteroids for painful interphalangeal joints (conditional recommendation) 2, 1
3. Chondroitin sulfate may provide symptom relief (conditional recommendation) 2, 1

The key principle: Always prioritize topical over systemic NSAIDs when feasible for hand OA 1.